Wockhardt Q4 Results

  • BSE: 532300
  • NSE: WOCKPHARMA
  • ISIN: INE049B01025
  • Sector: Biotechnology & Drugs
BSE
1,357.5517.80 (1.33%)
Volume16.08 K
Updated: Tue 16 Dec, 2025 | 15:29:05
NSE
1,357.2016.20 (1.21%)
Volume3.88 L
Updated: Tue 16 Dec, 2025 | 15:53:54
Today: 1,330.00
1,365.00
52-Wk: 1,109.60
1,870.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Wockhardt Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 25Dec 24QoQ CompMar 24YoY Comp
    Total Operating Expense 717.00680.005.44%807.00-11.15%
    Depreciation/ Amortization 53.0055.00-3.64%58.00-8.62%
    Operating Income 26.0041.00-36.59%-,107.000.00%
    Net Income -25.0014.000.00%-,169.00-85.21%
    Other Operating Expenses Total 238.00199.0019.60%219.008.68%
    Net Income Before Taxes -22.0021.000.00%-,180.00-87.78%
    Total Revenue 743.00721.003.05%700.006.14%
    Selling/ General/ Admin Expenses Total 166.00164.001.22%157.005.73%
    Diluted Normalized EPS -1.570.910.00%-5.80-72.97%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market